Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy

July 25, 2024 updated by: Lu Xing, West China Second University Hospital
In this study, the investigators summarize the existing best evidence of intermittent catheterization in patients after radical cervical cancer surgery from the perspective of clinical translation of evidence through systematic search, evaluation and evidence integration, construct a nursing protocol of intermittent catheterization for patients after radical cervical cancer surgery based on the best evidence combined with the clinical context, and explore the clinical application effect of the above nursing protocol. It will provide a reference basis for the development of the standardization and management of intermittent catheterization for postoperative patients with cervical cancer in China, as well as the development of guidelines for intermittent catheterization after radical cervical cancer surgery.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China
        • Recruiting
        • West China Second University Hospital, Sichuan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≧ 18 years old
  • Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital
  • Patients or their family members can operate a smartphone
  • No cognitive or psychiatric disorders, and can communicate effectively

Exclusion Criteria:

  • People with serious heart, brain, lung and other important organ diseases
  • People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization
  • People with previous serious renal diseases, bladder and urethra surgery
  • People with urinary tract infections
  • People who did not complete all interventions or data collection
  • People who voluntarily withdrew from the study or died during the study period;
  • Refuse to participate in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A best evidence-based protocol for intermittent catheterization
A best evidence-based protocol for intermittent catheterization after radical cervical cancer surgery
No Intervention: Routine intermittent catheterization care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of urinary complications
Time Frame: Within 2 months of discharge
the occurrence of urologic complications within 2 months after discharge of the patients from the hospital for follow-up, which in this study included urinary tract infections, urethral injuries, bladder stones, hydronephrosis
Within 2 months of discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intermittent Catheterization Compliance Scale
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
A questionnaire was used to investigate patients' adherence to carrying out intermittent catheterization before the intervention, immediately after the intervention, and 1 month after discharge from the hospital. Higher scores indicate better adherence.
Pre-intervention, immediately post-intervention, and 1 month post-discharge
12-Item Short Form Survey
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
A questionnaire was used to investigate patients' quality of life before and immediately after the intervention and 1 month after discharge. Higher scores indicate better quality of life.
Pre-intervention, immediately post-intervention, and 1 month post-discharge
Self-Rating Anxiety Scale
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
A questionnaire was used to investigate patients' anxiety before and immediately after the intervention and 1 month after discharge from the hospital. Higher scores indicate greater anxiety.
Pre-intervention, immediately post-intervention, and 1 month post-discharge
Intermittent Catheterization Confidence Scale
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
A questionnaire was used to investigate patients' self-efficacy before and immediately after the intervention and 1 month after discharge from the hospital. Higher scores indicate greater confidence.
Pre-intervention, immediately post-intervention, and 1 month post-discharge
Utilization of health services
Time Frame: Within 2 months of discharge
Follow-up to record the number of unplanned readmissions, outpatient visits, and emergency room visits within 2 months of discharge and to evaluate the patient's health service utilization
Within 2 months of discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

December 10, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

July 20, 2024

First Submitted That Met QC Criteria

July 25, 2024

First Posted (Actual)

July 31, 2024

Study Record Updates

Last Update Posted (Actual)

July 31, 2024

Last Update Submitted That Met QC Criteria

July 25, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023203

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intermittent Catheterization

Clinical Trials on intermittent catheterization protocol based on the best evidence

Subscribe